...
首页> 外文期刊>Asia-Pacific Biotech News >Japanese Biotech JCR Pharmaceuticals Selects Medidata's Cloud-Based Platform to Power Rare Disease Clinical Research in Japan
【24h】

Japanese Biotech JCR Pharmaceuticals Selects Medidata's Cloud-Based Platform to Power Rare Disease Clinical Research in Japan

机译:日本生物技术公司JCR Pharmaceuticals选择Medidata基于云的平台来推动日本罕见病临床研究

获取原文
获取原文并翻译 | 示例
           

摘要

Innovative Specialty Biopharma Adopts Medidata Technology to Bring Operational Efficiencies and Greater Speed to Cutting-Edge Research on Fabry DiseaseMedidata, the leading global provider of eloud-based solutions for clinical research in life sciences, today announced that its cloud-based technology platform has been adopted by JCR Pharmaceuticals Co., Ltd. The Japanese pioneer in bio-therapeutics isleveragingthe Medidata Clinical Cloud~R to support research on a therapy for the treatment of Fabry disease, bringing greater speed and operational efficiencies to the organization's development program in Japan.
机译:创新的专业生物制药公司采用Medidata技术提高法布里疾病的前沿研究效率全球领先的生命科学临床研究基于eloud的解决方案的全球提供商Medidata今天宣布已采用基于云的技术平台日本生物疗法的先驱,利用Medidata Clinical Cloud〜R支持法布里疾病治疗疗法的研究,为该组织在日本的开发计划带来了更快的速度和更高的运营效率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号